DISEASE AND ACETYLATION POLYMORPHISM

被引：153

作者：

LUNDE, PKM

FRISLID, K

HANSTEEN, V

机构：

[1] ULLEVAL HOSP, DIV CLIN PHARMACOL & TOXICOL, CENT LAB, OSLO, NORWAY

[2] ULLEVAL HOSP, DEPT MED 8, OSLO, NORWAY

来源：

CLINICAL PHARMACOKINETICS | 1977年 / 2卷 / 03期

关键词：

D O I：

10.2165/00003088-197702030-00003

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：182 / 197

页数：16

共 100 条

[1] DRUG-INDUCED ANTINUCLEAR ANTIBODIES AND LUPUS SYNDROMES [J].

ALARCONSEGOVIA, D .

DRUGS, 1976, 12 (01) :69-77

[2] ISONIAZID ACETYLATION RATE AND DEVELOPMENT OF ANTINUCLEAR ANTIBODIES UPON ISONIAZID TREATMENT [J].

ALARCONSEGOVIA, D ;

FISHBEIN, E ;

ALCALA, H .

ARTHRITIS AND RHEUMATISM, 1971, 14 (06) :748-+

[3]

AMLIE JP, IN PRESS

[4]

ARMSTRONG AR, 1960, AM REV RESPIR DIS, V81, P588

[5]

ATKINSON AJ, 1972, CLIN CHEM, V18, P643

[6] INDUCTION OF TRYPTOPHAN OXYGENASE BY DEXAMETHASONE IN ISOLATED HEPATOCYTES - DEPENDENCE ON COMPOSITION OF MEDIUM AND PH [J].

BERG, T ;

MORLAND, J .

BIOCHIMICA ET BIOPHYSICA ACTA, 1975, 392 (02) :233-241

[7]

BONICKE R, 1953, ARCH EXP PATHOL PH, V220, P321

[8] PHARMACOKINETICS OF ISONIAZID AND SOME METABOLITES IN MAN [J].

BOXENBAUM, HG ;

RIEGELMAN, S .

JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1976, 4 (04) :287-325

[9] DETERMINATION OF ISONIAZID AND METABOLITES IN BIOLOGICAL-FLUIDS [J].

BOXENBAUM, HG ;

RIEGELMAN, S .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1974, 63 (08) :1191-1197

[10] ACETYLATOR PHENOTYPE AND CLINICAL PHARMACOLOGY OF SLOW-RELEASE PROCAINAMIDE [J].

CAMPBELL, W ;

TILSTONE, WJ ;

LAWSON, DH ;

HUTTON, I ;

LAWRIE, TDV .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1976, 3 (06) :1023-1026

← 1 2 3 4 5 6 7 8 9 10 →